Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
In-Depth Treatment Profile
In-Depth Treatment Profile
,
FDA Approvals
,
Bispecific Antibodies
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile
,
A Payer Perspective
,
FDA Approvals
,
Bispecific Antibodies
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile
,
Multiple Myeloma
,
Oncology
,
Bispecific Antibodies
Ongoing Analyses and Recent Data for Talvey in Multiple Myeloma
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile
Imdelltra Approved for Treatment of Extensive-Stage Small Cell Lung Cancer on or Following Disease Progression While on Platinum-Based Chemotherapies
Rohan Vashi, PharmD, MSc
Read More
Results 1 - 4 of 4